loading page

Can a high visceral adiposity index predict female sexual dysfunction in sexually active women? Results of a cross-sectional study.
  • +2
  • Ramazan Aşçı,
  • Mustafa Bolat,
  • Cihad Dündar,
  • Ayse Zehra Ozdemir,
  • Aysegul Atmaca
Ramazan Aşçı
Ondokuz Mayis University Faculty of Medicine

Corresponding Author:[email protected]

Author Profile
Mustafa Bolat
Gazi State Hospital
Author Profile
Cihad Dündar
Ondokuz Mayis University
Author Profile
Ayse Zehra Ozdemir
Ondokuz Mayis University
Author Profile
Aysegul Atmaca
Ondokuz Mayis University
Author Profile

Abstract

Aims: To our knowledge, this is the first study investigating the impact of high visceral adiposity index on female sexual dysfunction (FSD). We aimed to show the impact of increased levels of visceral adiposity index (VAI) on FSD compared to body mass index (BMI) and waist circumference (WC). Methods: We included 158 participants in two groups: Group 1 (n=68 with normal sexual function) and Group 2 (n=90 with sexual dysfunction). Demographic, clinic data, presence of metabolic syndrome (MeTS) and comorbidities were recorded. The BMI, WC and the visceral adiposity index were calculated. Sexual function was assessed using the female sexual function index (FSFI). Results: The mean age and all the anthropometric variables were similar between the groups (p>0.05). Metabolic syndrome was associated with lower arousal and lubrication scores than those without metabolic syndrome (p=0.023). The higher VAI was associated with lower desire, lubrication and orgasm scores (p<0.05). Each integer increase of the VAI weakly predicted decrease of desire (p=0.015), arousal (p=0.015), lubrication (p=0.005) and satisfaction (p=0.046). Conclusion: The VAI was linked with lower scores in some female sexual function subdomains, but the correlation coefficient was low, indicating a weak association. Further studies with a higher number of participants are needed to conclude that the VAI may increase the risk of FSD, particularly in patients with metabolic syndrome.
10 May 2021Submitted to International Journal of Clinical Practice
12 May 2021Submission Checks Completed
12 May 2021Assigned to Editor
12 May 2021Reviewer(s) Assigned
29 May 2021Review(s) Completed, Editorial Evaluation Pending
13 Jun 2021Editorial Decision: Revise Minor
15 Jun 20211st Revision Received
16 Jun 2021Submission Checks Completed
16 Jun 2021Assigned to Editor
16 Jun 2021Review(s) Completed, Editorial Evaluation Pending
25 Jun 2021Reviewer(s) Assigned
05 Jul 2021Editorial Decision: Revise Minor
05 Jul 20212nd Revision Received
06 Jul 2021Submission Checks Completed
06 Jul 2021Assigned to Editor
06 Jul 2021Review(s) Completed, Editorial Evaluation Pending
06 Jul 2021Editorial Decision: Accept